Revenue · 2011–2025
Novavax revenue
$1.1B+64.7% · FY2025
Novavax (NVAX) reported $1.1B in revenue for fiscal 2025, +64.7% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $1.1B | +64.7% | Open → |
| FY20242024-12-31 | $682M | −30.7% | Open → |
| FY20232023-12-31 | $984M | −50.4% | Open → |
| FY20222022-12-31 | $2.0B | +72.9% | Open → |
| FY20212021-12-31 | $1.1B | +141.0% | Open → |
| FY20202020-12-31 | $476M | +2,448.5% | Open → |
| FY20192019-12-31 | $18.7M | −45.6% | Open → |
| FY20182018-12-31 | $34.3M | +10.0% | Open → |
| FY20172017-12-31 | $31.2M | +103.1% | Open → |
| FY20162016-12-31 | $15.4M | −57.6% | Open → |
| FY20152015-12-31 | $36.3M | +18.2% | Open → |
| FY20142014-12-31 | $30.7M | +46.6% | Open → |
| FY20132013-12-31 | $20.9M | −5.3% | Open → |
| FY20122012-12-31 | $22.1M | +50.3% | Open → |
| FY20112011-12-31 | $14.7M | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +36.3%
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Novavax revenue |url=https://companiesranked.com/en/company/novavax/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Novavax revenue. CompaniesRanked. https://companiesranked.com/en/company/novavax/revenueBibTeX
@misc{companiesranked-en-company-novavax-revenue-2026,
author = {{CompaniesRanked}},
title = {{Novavax revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/novavax/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001000694-26-000007 · February 26, 2026
{{cite web |title=Novavax revenue — 10-K (0001000694-26-000007) |url=https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.